A European regulatory committee has rejected Eli Lilly’s U.S.-approved Alzheimer’s disease treatment over potentially ...

The full extent of death, injury and destruction was not immediately clear- particularly in Myanmar, which is embroiled in a ...

The total number of fatalities is 'most likely to be in the range 10,000-100,000', scientists have warned, citing the United States Geological Survey 'PAGER' forecast.

The Canadian prime minister's office said Trump and Mark Carney had a "very constructive conversation about the relationship ...

A European health committee has rejected Eli Lilly’s Alzheimer’s drug, Kisunla, because of safety concerns about possible brain swelling and bleeding. Although the drug is alr ...

After failing to pass muster with England’s drug reimbursement watchdog earlier this month, Eli Lilly’s Alzheimer’s disease ...

According to data compiled by S&P Global Market Intelligence, Viasat (NASDAQ: VSAT) stock was up by more than 17% week to date as of early Friday morning. Investors were cheered by news of the ...

The company behind the drug donanemab said it will ask regulators to reconsider the decision. View on euronews ...

The EU medicines regulator on Friday rejected Eli Lilly's Alzheimer's drug, saying the treatment's ability to slow cognitive ...

Eli Lilly's Kisunla was approved in the U.S. for Alzheimer's last year, but now advisers to the European Medicines Agency say it shouldn't be approved.

Can Americans afford Trump’s tariffs? GOP’s Stefanik staying put in House RFK Jr. unveils seismic HHS layoffs, overhaul ...